Cargando…

Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease

BACKGROUND: Frailty is characterized by the loss of biological reserves and vulnerability to adverse outcomes. In individuals with chronic kidney disease (CKD), numerous pathophysiological factors may be responsible for frailty development including inflammation, physical inactivity, reduced energy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkinson, Thomas J., Miksza, Joanne, Zaccardi, Francesco, Lawson, Claire, Nixon, Andrew C., Young, Hannah M.L., Khunti, Kamlesh, Smith, Alice C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530530/ https://www.ncbi.nlm.nih.gov/pubmed/35851589 http://dx.doi.org/10.1002/jcsm.13047

Ejemplares similares

Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study
por: Wilkinson, Thomas J., et al.
Publicado: (2021)

Association of Ethnicity and Socioeconomic Status With COVID-19 Hospitalization and Mortality in Those With and Without Chronic Kidney Disease
por: Wilkinson, Thomas J., et al.
Publicado: (2021)

Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
por: Zaccardi, Francesco, et al.
Publicado: (2020)

Kidney Function and Long-Term Risk of End-Stage Kidney Disease and Mortality in a Multiethnic Population
por: Ling, Suping, et al.
Publicado: (2023)

Cardiovascular risk profiles and the uptake of the NHS Healthcheck programme in male prisoners in six UK prisons: an observational cross-sectional survey
por: Packham, Christopher, et al.
Publicado: (2020)

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi‐ethnic population
por: Coles, Briana, et al.
Publicado: (2020)

Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
por: Vetrone, Lorenzo M., et al.
Publicado: (2018)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold
por: Butcher, Elizabeth, et al.
Publicado: (2021)

Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study
por: Spanopoulos, Dionysis, et al.
Publicado: (2019)

Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years
por: Lawson, Claire A, et al.
Publicado: (2021)

Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017
por: Lawson, Claire A., et al.
Publicado: (2019)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies
por: Zaccardi, Francesco, et al.
Publicado: (2016)

Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates
por: Zaccardi, Francesco, et al.
Publicado: (2018)

Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England
por: Ling, Suping, et al.
Publicado: (2023)

Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: ‘Multimorbidity and SARS-CoV-2 infection in UK Biobank’ (Chudasama et al.)
por: Chudasama, Yogini V, et al.
Publicado: (2020)

Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
por: Ayoubkhani, Daniel, et al.
Publicado: (2022)

Safety of antidepressants in a primary care cohort of adults with obesity and depression
por: Morriss, Richard, et al.
Publicado: (2021)

A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England
por: Yates, Thomas, et al.
Publicado: (2022)

Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study
por: Hawthorne, Grace, et al.
Publicado: (2023)

Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
por: Norris, Tom, et al.
Publicado: (2022)

Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study
por: Yates, Thomas, et al.
Publicado: (2017)

Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
por: Yates, Thomas, et al.
Publicado: (2021)

Symptom-burden in people living with frailty and chronic kidney disease
por: Nixon, A. C., et al.
Publicado: (2020)

Promoting inclusion in clinical trials—a rapid review of the literature and recommendations for action
por: Bodicoat, Danielle H., et al.
Publicado: (2021)

Frailty and risk of cardiovascular disease and mortality
por: Liu, Xiao, et al.
Publicado: (2022)

Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Frailty Component Trajectories After Restoration of Kidney Function Among Kidney Transplant Recipients
por: Chu, Nadia, et al.
Publicado: (2020)

20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study
por: Lawson, Claire A, et al.
Publicado: (2019)

Obesity and risk of COVID-19: analysis of UK biobank
por: Yates, Thomas, et al.
Publicado: (2020)

Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?
por: Bai, Ge, et al.
Publicado: (2021)

The effect of pharmacist‐led interventions on the management and outcomes in chronic kidney disease (CKD): A systematic review and meta‐analysis protocol
por: Ardavani, Ashkon, et al.
Publicado: (2023)

Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis
por: Murali, Mayur, et al.
Publicado: (2023)

Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia
por: Lawson, Claire A., et al.
Publicado: (2023)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

Joint Prevalence of Diabetes, Impaired Glucose Regulation, Cardiovascular Disease Risk and Chronic Kidney Disease in South Asians and White Europeans
por: Khunti, Kamlesh, et al.
Publicado: (2013)

Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort
por: Yates, Thomas, et al.
Publicado: (2021)

Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
por: Nixon, Andrew C, et al.
Publicado: (2019)

Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
por: Nixon, Andrew C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c3pjn71hbd8t1t4fl4drbirdee